085660 — Chabiotech Co Share Price
0.000.00%
Last trade - 00:00- KR₩697bn
- KR₩2tn
- KR₩1tn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.45 | ||
| Price to Tang. Book | 10.14 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.67 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -4.09% | ||
| Return on Equity | -2.85% | ||
| Operating Margin | -4.59% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 664,716.83 | 727,476.09 | 844,582.87 | 953,951.42 | 1,045,049.02 | n/a | n/a | 14.35% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Chabiotech Co.,Ltd. is a Korea-based company mainly engaged in the bio business. Along with its subsidiaries, the Company operates its business through two segments: bio segment and optical segment. Its bio segment engages in the provision of medical services; development of stem cells and cell therapy products; production of cosmetics and cosmetic raw materials; distribution of medical devices and others, as well as cord blood storage, health care services and others. Its optical segment engages in the manufacture of optical lenses, optical modules and other parts, which are used in mobile phone cameras.
Directors
- Gyu Beom Han CPR (52)
- Hyeong Min Jung CPR (48)
- Sang Hun Oh CEO (55)
- Byeong Wu Moon VCH (60)
- Gyeong Wuk Yoon VPR (46)
- Jong Guk Song MDR (52)
- Jin Hwan Kim OTH (43)
- Yeong Han Kim OTH (60)
- Sang Won Lee OTH (46)
- Jeong Rim Nam OTH (53)
- Yin Su Park OTH (70)
- Byeong Geun Song OTH (52)
- Jung Chil Yum OTH (53)
- Jung Ho Kim NID (69)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 5th, 2002
- Public Since
- December 27th, 2005
- No. of Shareholders
- 47,641
- No. of Employees
- 121
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 60,633,431.45
- Address
- 3F, SEOUL, 06062
- Web
- https://www.chabio.com/
- Phone
- +82 230155590
- Auditors
- Daejoo Accounting Corp.
Upcoming Events for 085660
Q2 2025 Chabiotech Co Ltd Earnings Release
Similar to 085660
Biotoxtech Co
Korea Exchange - KOSDAQ
DreamCIS
Korea Exchange - KOSDAQ
DT&CRO Co
Korea Exchange - KOSDAQ
GC Cell
Korea Exchange - KOSDAQ
Labgenomics Co
Korea Exchange - KOSDAQ
FAQ
What is the Chabiotech Co share price?
As of Today at 19:51 UTC, shares in Chabiotech Co are trading at KR₩11,500. This share price information is delayed by 15 minutes.
How has the Chabiotech Co share price performed this year?
Shares in Chabiotech Co last closed at KR₩11,500 and the price had moved by -27.08% over the past 365 days. In terms of relative price strength the Chabiotech Co share price has underperformed the FTSE Developed Asia Pacific Index by -26.25% over the past year.
What are the analyst and broker recommendations for Chabiotech Co?
The overall consensus recommendation for Chabiotech Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Chabiotech Co dividend yield?
Chabiotech Co does not currently pay a dividend.
Does Chabiotech Co pay a dividend?
Chabiotech Co does not currently pay a dividend.
When does Chabiotech Co next pay dividends?
Chabiotech Co does not currently pay a dividend.
How do I buy Chabiotech Co shares?
To buy shares in Chabiotech Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Chabiotech Co?
As of the previous close price of KR₩11,500, shares in Chabiotech Co had a market capitalisation of KR₩697bn.
Where are Chabiotech Co shares listed?
Here are the trading details for Chabiotech Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 085660
What kind of share is Chabiotech Co?
Based on an overall assessment of its quality, value and momentum Chabiotech Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Chabiotech Co share price forecast for 2025?
The analyst consensus target price for shares in Chabiotech Co is KR₩21,400. That is 86.09% above the last closing price of KR₩11,500.
Analysts covering Chabiotech Co currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Chabiotech Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chabiotech Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -22.96%.
As of the last closing price of KR₩11,500, shares in Chabiotech Co were trading -12.93% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Chabiotech Co PE Ratio?
The Chabiotech Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩11,500.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Chabiotech Co?
Chabiotech Co's management team is headed by:
- Gyu Beom Han - CPR
- Hyeong Min Jung - CPR
- Sang Hun Oh - CEO
- Byeong Wu Moon - VCH
- Gyeong Wuk Yoon - VPR
- Jong Guk Song - MDR
- Jin Hwan Kim - OTH
- Yeong Han Kim - OTH
- Sang Won Lee - OTH
- Jeong Rim Nam - OTH
- Yin Su Park - OTH
- Byeong Geun Song - OTH
- Jung Chil Yum - OTH
- Jung Ho Kim - NID